Skip to main content

Market Overview

64 Biggest Movers From Friday

Share:

Gainers

  • Endo International plc (NASDAQ: ENDP) shares surged 47.7% to close at $3.4850 on Friday after the company announced it has submitted a biologics license application to the FDA for collagenase clostridium histolyticum for the treatment of cellulite in the buttocks.
  • Microbot Medical Inc. (NASDAQ: MBOT) rose 44.4% to close at $7.06.
  • Pier 1 Imports, Inc. (NYSE: PIR) gained 25.7% to close at $6.16.
  • DocuSign, Inc. (NASDAQ: DOCU) shares rose 21.7% to close at $56.27 after the company reported better-than-expected Q2 sales results.
  • Hovnanian Enterprises, Inc. (NYSE: HOV) rose 20.6% to close at $12.69.
  • Autolus Therapeutics plc (NASDAQ: AUTL) shares climbed 18.1% to close at $14.09 on Friday.
  • Applied Genetic Technologies Corporation (NASDAQ: AGTC) rose 17.5% to close at $3.76 after Janney Capital initiated coverage on the stock with a Buy rating.
  • NeuBase Therapeutics, Inc. (NASDAQ: NBSE) surged 17.1% to close at $5.95.
  • Carbonite, Inc. (NASDAQ: CARB) gained 16.6% to close at $15.08.
  • Organogenesis Holdings Inc. (NASDAQ: ORGO) climbed 16.4% to close at $5.40.
  • Lannett Company, Inc. (NYSE: LCI) shares rose 15.2% to close at $13.16 after a company insider bought 25,000 shares at an average price of $9.82 per shares. When an insider buys shares, the market may perceive it as a sign of confidence in the company's outlook.
  • Guidewire Software, Inc. (NYSE: GWRE) gained 14.7% to close at $109.41 after reporting upbeat quarterly results.
  • Neon Therapeutics, Inc. (NASDAQ: NTGN) shares climbed 14.4% to close at $3.33 after the company announced its breakthrough process for predicting which neoantigens will be presented by MHC class II molecules in the tumor microenvironment was published in the scientific journal, Immunity.
  • Francesca's Holdings Corporation (NASDAQ: FRAN) gained 14.1% to close at $4.86.
  • electroCore, Inc. (NASDAQ: ECOR) climbed 13.3% to close at $2.89.
  • Orchard Therapeutics plc (NASDAQ: ORTX) gained 12.4% to close at $16.72.
  • Pfenex Inc. (NYSE: PFNX) shares jumped 12.1% to close at $8.63. Pfenex said it has earned an $11 million development milestone under its development and license agreement with Jazz Pharmaceuticals regarding PF745, a recombinant crisantaspase with half-life extension technology – a chemotherapy drug used to treat acute lymphoblastic leukemia.
  • BEST Inc. (NYSE: BEST) climbed 11.6% to close at $5.49.
  • Zumiez Inc. (NASDAQ: ZUMZ) rose 11.3% to close at $30.71 after the company reported better-than-expected results for its second quarter and issued strong third-quarter guidance.
  • MoneyGram International, Inc. (NASDAQ: MGI) gained 11.1% to close at $5.22.
  • At Home Group Inc. (NYSE: HOME) rose 11% to close at $7.24 after Clifford Sosin, a company insider, bought 85,000 shares at an average price of $6.55 per shares. When an insider buys shares, the market may perceive it as a sign of confidence in the company's outlook.
  • Galectin Therapeutics, Inc. (NASDAQ: GALT) gained 10.9% to close at $3.77.
  • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 10.5% to close at $2.95.
  • Sutro Biopharma, Inc. (NASDAQ: STRO) climbed 10.1% to close at $9.50.
  • R.R. Donnelley & Sons Company (NYSE: RRD) gained 10% to close at $2.74.
  • SeaChange International, Inc. (NASDAQ: SEAC) climbed 10% to close at $3.07.
  • Comstock Resources, Inc. (NYSE: CRK) gained 9.4% to close at $8.23.
  • comScore, Inc. (NASDAQ: SCOR) rose 8.9% to close at $2.21.
  • Lululemon Athletica Inc. (NASDAQ: LULU) rose 7.8% to close at $203.14 after the company reported better-than-expected Q2 EPS and sales results. The company also issued Q3 EPS and sales guidance above analyst estimates.
  • DURECT Corporation (NASDAQ: DRRX) rose 7.2% to close at $1.78 after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and a price target of $5 per share.
  • Immunic Inc (NASDAQ: IMUX) shares gained 6.9% to close at $13.79 after the company reported data from its Phase 2 CALDOSE-1 study evaluating IMU-838 in moderate-to-severe ulcerative colitis patients. Data showed activity in the low dose and tolerability in the high dose.
  • Amneal Pharmaceuticals, Inc. (NYSE: AMRX) climbed 6.9% to close at $2.94.
  • JAKKS Pacific, Inc. (NASDAQ: JAKK) shares gained 6.7% to close at $0.8000 after the company confirmed that it has received an additional non-binding expression of interest to acquire all of the shares of the company's common stock for $0.85-$0.90 per share.
  • Tailored Brands, Inc. (NYSE: TLRD) shares rose 6.4% to close at $5.52.
  • Corporación América Airports S.A. (NYSE: CAAP) shares rose 5.4% to close at $5.31.
  • Unity Biotechnology, Inc. (NYSE: UBX) climbed 5.3% to close at $6.73.
  • Nesco Holdings, Inc. (NYSE: NSCO) shares surged 3.7% to close at $6.49. Deutsche Bank initiated coverage on Nesco Holdings with a Buy rating and a $8 price target.
  • Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) shares gained 3.6% to close at $0.58 on Friday after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and a price target of $1 per share.

Check out these big penny stock gainers and losers

Losers

  • Domo, Inc. (NASDAQ: DOMO) shares tumbled 37.5% to close at $15.77 on Friday. Domo reported upbeat results for its second quarter, but issued Q3 and FY20 guidance below analyst estimates.
  • Avid Bioservices, Inc. (NASDAQ: CDMO) declined 23% to close at $5.43 after the company reported worse-than-expected Q1 EPS results.
  • PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) dipped 19.5% to close at $5.05.
  • Modern Media Acquisition Corp. (NASDAQ: MMDM) shares dipped 18.9% to close at $7.30 on Friday.
  • NextCure, Inc. (NASDAQ: NXTC) shares declined 17.5% to close at $34.34.
  • Plus Therapeutics, Inc. (NASDAQ: PSTV) dropped 14.9% to close at $10.05.
  • Edesa Biotech, Inc. (NASDAQ: EDSA) fell 13% to close at $5.20 after climbing 52.94% on Thursday.
  • Arcadia Biosciences, Inc. (NASDAQ: RKDA) dipped 13% to close at $6.54 after the company announced a 1.319 million share common stock offering at $7.5825 per share.
  • CrowdStrike Holdings, Inc. (NASDAQ: CRWD) fell 12.5% to close at $75.98 despite the company reporting better-than-expected Q2 EPS and sales results.
  • Synchronoss Technologies, Inc. (NASDAQ: SNCR) fell 11.9% to close at $6.50.
  • PagerDuty, Inc. (NYSE: PD) fell 11.3% to close at $32.47 despite reporting upbeat Q2 results.
  • Walker & Dunlop, Inc. (NYSE: WD) fell 11.3% to close at $50.88 after Keefe Bruyette & Woods downgraded the stock from Outperform to Market Perform and lowered the price target from $65 to $64 per share.
  • Everbridge, Inc. (NASDAQ: EVBG) shares declined 10.6% to close at $74.15.
  • Castor Maritime Inc. (NASDAQ: CTRM) fell 10.5% to close at $2.74.
  • REV Group, Inc. (NYSE: REVG) shares declined 9.8% to close at $8.28.
  • InMode Ltd. (NASDAQ: INMD) fell 9.7% to close at $24.14.
  • Turning Point Therapeutics, Inc. (NASDAQ: TPTX) dropped 9% to close at $42.75 after the company priced its common stock offering of 4.5 million shares at $45 per share.
  • OpGen, Inc. (NASDAQ: OPGN) shares dipped 8.9% to close at $7.00.
  • Slack Technologies, Inc. (NYSE: WORK) fell 8.8% to close at $27.38 on continued momentum after the company issued Q3 EPS guidance below analyst estimates. The company's CEO and CTO sold a total of 4,000 shares at an average price of $28.41 per share.
  • Mersana Therapeutics, Inc. (NASDAQ: MRSN) dipped 8.7% to close at $2.10.
  • Workhorse Group Inc. (NASDAQ: WKHS) shares fell 8.4% to close at $3.39.
  • Science Applications International Corporation (NYSE: SAIC) tumbled 8.1% to close at $83.08 after the company reported worse-than-expected Q2 sales results.
  • Spherix Incorporated (NASDAQ: SPEX) fell 8% to close at $2.18.
  • U.S. Global Investors, Inc. (NYSE: GROW) fell 7.7% to close at $1.93 after the company reported Q4 EPS and sales results down from last year.
  • Korn Ferry (NYSE: KFY) dipped 6.7% to close at $36.72 after the company issued Q2 EPS guidance below analyst estimates. Credit Suisse also maintained an Underperform rating and lowered the price target from $40 to $37.
  • MRC Global Inc (NYSE: MRC) shares fell 5.2% to close at $12.08 after the company issued Q3 sales guidance below analyst estimates.
 

Related Articles (AMRX + AGTC)

View Comments and Join the Discussion!

Posted-In: Movers From FridayNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com